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ing MITP9. Interestingly, homozy- 
gotes for the spontaneous mouse 
mutation Zs//s1()>l 1 as well as the 
Edn3 knockout mouse4 also show 
depigmentation in combination 
with colonic aganglionosis. In this 
pedigree the affected children with 
presumably the same EDN3 muta­
tion show different extents of agan­
glionosis. Modifying genes and/or 
environmental factors may account 
for such a difference,
Mutation screening of the 
EDNRB gene revealed heterozygous 
variations in exon 1 in three HSCR 
patients and in exon 6 in a single 
patient (results not shown). The 
variations in exon 1 all proved to be 
a G—>A transition, resulting in the 
substitution of a serine for a glycine 
in codon 57. This variant was also 
present heterozygously in 4 out of 90 control individu­
als. Therefore, we consider it a non-causative poly­
morphism. The exon 6 variant turned out to be a 
novel mutation, namely a G—>A transition resulting in 
the substitution of an isoleucine for a methionine in 
codon 374. As this mutation creates the loss of an Altil 
site, presence of the mutation could be confirmed by
0
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ó  0  □  □  a
H SCR
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0  sensorineural hearing loss
E  pigmentary disorders 
Q  hypoplastic blue eyes
Fig. 2 Pedigree of the family in which presence of a homozygous EDN3 mutation was 
demonstrated for IV.3. Besides this patient, his parents (111,3 and 111.4) and his uncle on 
fathers side (It 1.1) were tested. All three were heterozygous for the mutation.
restriction analysis (data not shown). This mutation 
did not occur in 100 control subjects. Methionine 374 
is present in transmembrane domain VII of the 
EDNRB protein. The mutation might, therefore, affect 
proper anchoring and functioning of the protein.
Homozygotes for the spontaneous mouse mutations 
s*/5* and its knock-out counterpart, E d i i r l r (ref, 12)
......... .... ......... .................. 1*1 I ............... ..
Table 1 BDN3 and EDNRB primer sequences and conditions
Gene Exon Primer bp Ann. UF
temp gradient
EDN3
1 p* GCGCGCTCTGAAAGTTTATG 345 57+ 40-80
R AAGAG11 i GCTCCCTGCGAC
2a F CACAGAGTGTGCAGATAGCT 425 57 40-80
R* GTCCTTGTAGGTGAAGCACG
2b F* G G ACTGTG AAGAG ACT GIG G 408 57 40-80
R TGACCTGCAGAAGAGACCTG
3 F GOT C ACCTAAC ATTAC COT G 295 55 50-100
R* TAC ACC CTC CTTTG AG AAG C
4a p* CCAGTGTGAACTGCATGGTT 322 57+ 30-60
R TCTGTTGGCACTCTCACCTT
4b F C AGTAATT C AAGG ACGG C AG 270 57 40-80
R* CG AC AAGTG AC AG C AGCT GT
5a p ACATACAGTTCCAATCAGGG 196 55 25-65
R* CATGAGCTTTGGATGGTGGA
5b F GAAGTCAAGGACCAACAAAG 181 57 40-80
R* GT GT GTGAG CAAT G AC AG AAG
EDNRB
1a F* C CT GT CTT C CTT C CTCTG CT 336 57 40-80
R AGATGGTGCGTGGCGGAGAT
1b F ACCTGCGGAGGTGCCTAAAG 357 55+ 40—80
R* AG CTTT CTCAT CTCCCCGTC
2 F* A GT G ATACAATT CAGA G G G C 203 47 40-80
R TACTTGG ATTAAATAG AAGC
3a F TGCT G AGT CTAT GT G CTCTG 230 55 20-60
R* ACTGCTGTCCAl I ! IGGAAC
3b F* CTGTTGCTTCTTGGAGTAGA 292 52+ 25-65
R CAACAGTTTCCCAAGGAGTG
4 F* AG ATAAT C ATT C CCT GAT G A 298 57 20-60
R AAATT C AAC C AC G AGITAT C
5 F* AGT CACTI CGGTT CC ACTT C 362 55+ 20-60
R G G AAAC ACTT CT G AGT GGC A
6 F AC AG AAGCTAC AATG ACTAC 240 55+ 20-60
R* GAAAGGCTTATAI i I GAGCC
7 F* AAGG AAAGTC AG AACCCT G G 267 54 20-60
R G ACTT CG GT CCAATATAAAG
*1 ♦ V MJWI -WJX » I» t « _ Al 1 « 1 :< AiXUWHW u
(F) forward primer; (R) reverse primer; (*) 40 bp GC clamp attached (see Methods); (+) 10% DMSO in PCR
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show white spotting as a result of the absence of 
melanocytes. Such depigmentation is also a character­
istic of a number of EDNRB mutation carriers^» 
Apparently, a combined WS2-HSCR phenotype might 
be associated with mutations of either EDNRB or 
EDN3. However, in the patient with the EDNRB muta­
tion (Met374ile) no signs of WS2 were found. This 
was also true for the patient’s father, who turned out to 
carry the mutation as well, and for the patient's moth­
er. This might imply that mutations in EDNRB are not 
necessarily associated with a combined WS2-HSCR 
phenotype and that modifying genes have a role.
All 40 HSCR patients have also been screened for 
mutations of RET, with nine presumably causative 
RET mutations found (manuscript in preparation). 
The combined results of our screening for mutations 
in EDN3y EDNRB and RET may give some indication 
of the contributions of these genes to the HSCR phe­
notype. RET mutations seem to account for a large 
part of cases14™16; EDNRB and EDN3 only for a minor­
ity. We did not detect patients with mutations in more 
than one of the genes. The majority of HSCR cases 
cannot be explained by mutations in any of the genes 
analysed to date, suggesting that other genes may con­
tribute to the phenotype. A human homologue for the 
mouse dotn locus17 and genes coding for the enzymes 
involved in the cleavage of the preproendothelin are 
obvious candidates. Moreover, as suggested by the far 
from rare occurrence of nonpenetrance of known 
mutations, there may be a role of modifying genes 
conferring a true polygenic character to the disease.
Methods
Patients. DNA from 40 unselected HSCR patients was scanned 
for mutations of EDN3 and EDNRB. Of these 40, 9 were 
known to be familial. The EDN3 mutation was detected in a 
male infant. He was the third child of a healthy, phenotypically 
normal couple of Pakistani ancestry His parents were first 
cousins. His elder sister was diagnosed with total colonic agan- 
glionosis, profound bilateral hearing loss (>90 dB), hypoplas­
tic blue eyes and pigmentation disorders. The patient (Fig,2,
IV.3) was neonatally diagnosed with HSCR. Full thickness 
biopsies indicated that ganglion cells were absent from the 
entire gut starting 20 cm distal to the ligament of Treitz. The 
baby died at the age of 16 d. Clinical examination revealed a
white forelock in a dark haired infant and hypoplastic blue iri- 
des, slightly short neck (webbed), sacral dimple and pitting 
lymphoedema on hands and feet. There was no lateral dis­
placement of inner canthi. Brainstem electric response 
audiometry detected a bilateral severe hearing loss (left ear 50 
dB and right ear 80 dB), Chromosomal analysis showed a n o r ­
mal karyotype, 46,XY. A paternal unde (Fig. 2, JII.J), who was 
heterozygous for the mutation, and both grandfathers were 
reported with premature greying. In addition the parents’ 
grandfather had hypoplastic blue eyes. Deafness was reported 
in two sibs of the mother (Fig. 2, III.5, III.8).
The patient in which the exon 6 mutation in EDNRB was 
detected had no other anomalities besides a short segment 
HSCR. This patient and his parents showed no WS24ike 
symptoms.
DGGE and sequence analysis of EDN3 and EDNRB. Mutation 
analysis of EDN3 and EDNRB was performed using DGGE 
analysis for all exons. To one of .the primers of each set, a 40 bp 
CG clamp (cgcccgccgc gccccgcgcc cgtcccgccg cccccgcccg) was 
attached. The primers, PCR and DGGE conditions are given in 
Table 1. The electrophoresis buffer used for the DGGE analysis 
was 0.5x TAE (20 mM Tris-acetate, 10 mM sodium acetate, 1 
mM EDTA, pH 8.0) at a temperature of 58 °C. PCR products 
containing variants were cloned by the TA cloning kit (Invitro- 
gen). Mutant clones were selected on the basis of their DGGE 
patterns and sequenced using MI3 primers. To exclude PCR 
artefacts we cloned the variants from two independent PCR 
reactions and sequenced between 3 and 7 clones that all turned 
out to carry the mutation.
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